...
首页> 外文期刊>Analytical chemistry >Selection of DNA Aptamers That Recognize alpha-Synuclein Oligomers Using a Competitive Screening Method
【24h】

Selection of DNA Aptamers That Recognize alpha-Synuclein Oligomers Using a Competitive Screening Method

机译:使用竞争性筛选方法的识别α-突触核蛋白寡聚体的DNA适体的选择。

获取原文
获取原文并翻译 | 示例
           

摘要

alpha-Synuclein (alpha-syn) oligomers are considered major molecules responsible for the onset of Parkinson's disease and dementia with Lewy bodies. alpha-Syn oligomers thus serve as an important target for the development of drugs and diagnostic tests for neurodegenerative diseases. In this paper we report on the identification of DNA aptamers that bind to soluble alpha-syn oligomers. A competitive screening method based on aptamer blotting was used for the selection of alpha-syn oligomer-specific aptamers. This approach resulted in the identification of eight aptamers that specifically bind to alpha-syn oligomers among alpha-syn monomers, oligomers, and fibrils. Interestingly, the aptamers also bound to amyloid beta oligomers, which are strongly associated with the development of Alzheimer's disease. The results of this study support the hypothesis that amyloid oligomers share a common structure. Oligomer-binding aptamers may serve as powerful analytical tools for the design and development of drugs and diagnostic tests for neurodegenerative diseases.
机译:α-突触核蛋白(α-syn)低聚物被认为是导致帕金森氏病和路易体痴呆的主要分子。因此,α-Syn低聚物成为开发药物和神经退行性疾病的诊断测试的重要目标。在本文中,我们报告了与可溶性α-syn寡聚体结合的DNA适体的鉴定。使用基于适体印迹的竞争性筛选方法来选择α-syn低聚物特异性适体。该方法导致鉴定了八种与α-syn单体,寡聚物和原纤维中的α-syn寡聚物特异性结合的适体。有趣的是,适体还与淀粉样蛋白β低聚物结合,后者与阿尔茨海默氏病的发展密切相关。这项研究的结果支持淀粉样蛋白低聚物具有相同结构的假设。寡聚物结合适体可作为用于药物设计和开发以及神经退行性疾病诊断测试的强大分析工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号